Endocrinology, Vol 136, 412-420, Copyright © 1995 by Endocrine Society

ARTICLES

Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats

Y Fischer, J Thomas, P Rosen and H Kammermeier
Institute of Physiology, Medical Faculty Rheinisch-Westfalische Technische Hochschule, Aachen, Germany.

The effects of the antidiabetic drug metformin on glucose transport were investigated in freshly isolated heart muscle cells from healthy and streptozotocin-diabetic rats. In vivo treatment of diabetic rats with metformin failed to affect the basal and insulin-stimulated rate of glucose transport measured in isolated cells. In vitro exposure to therapeutic concentrations (< or = 10(-4) M) of metformin did not influence glucose transport, even upon incubation times up to 5 h or in the presence of high glucose (20 nM). In contrast, higher metformin concentrations produced an 8- to 12-fold increase in glucose uptake (with a lag of 90 min, and a maximum at 180 min and approximately 5 mM). In the presence of submaximal insulin concentrations (< or = 3.10(- 10) M), the effects of metformin (5 mM) and of insulin were more than additive, whereas, at saturating insulin concentrations (10(-8) M), partial additivity was observed. Like insulin, metformin caused an approximately 1.6-fold increase in the content of both glucose transporter isoforms GLUT1 and GLUT4 in the plasma membrane of cardiac myocytes, with a corresponding decrease in an intracellular membrane fraction. cAMP-elevating treatments depressed the metformin-, but not the insulin-dependent glucose uptake, by 20-30%. In myocytes from diabetic rats, the rate of metformin-activated glucose transport was similar to that of cells from control animals, whereas basal and insulin-stimulated transport were substantially diminished. Finally, metformin (5 mM) induced a slight depression of oxygen consumption and energy metabolism of myocytes (as determined by measuring their level of energy-rich phosphates) comparable to the effects of hypoxia in rat hearts. In conclusion, these data do not provide evidence in favor of the hypothesis that glucose uptake by muscle tissue represents the site of metformin's therapeutic action in vivo. On the other hand, the large, insulin-independent effect of metformin at high concentrations (approximately mM) in vitro may be related to the action of hypoxia and occurs through a redistribution of glucose carriers from an intracellular locus to the plasma membrane. The mechanism (or signal) involved in metformin's action is likely to differ from that triggered by insulin and is not impaired in the diabetic state.

This article has been cited by other articles:

				H. Sasaki, H. Asanuma, M. Fujita, H. Takahama, M. Wakeno, S. Ito, A. Ogai, M. Asakura, J. Kim, T. Minamino, et al. Metformin Prevents Progression of Heart Failure in Dogs: Role of AMP-Activated Protein Kinase Circulation, May 19, 2009; 119(19): 2568 - 2577. [Abstract] [Full Text] [PDF]

				J. J F P Luiken, D M. Ouwens, D. D J Habets, G. C M van der Zon, W. A Coumans, R. W Schwenk, A. Bonen, and J. F C Glatz Permissive action of protein kinase C-{zeta} in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes J. Endocrinol., May 1, 2009; 201(2): 199 - 209. [Abstract] [Full Text] [PDF]

				S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF]

				R. Saeedi, H. L. Parsons, R. B. Wambolt, K. Paulson, V. Sharma, J. R. B. Dyck, R. W. Brownsey, and M. F. Allard Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2497 - H2506. [Abstract] [Full Text] [PDF]

				E. M. Horvath, L. Tackett, A. M. McCarthy, P. Raman, J. T. Brozinick, and J. S. Elmendorf Antidiabetogenic Effects of Chromium Mitigate Hyperinsulinemia-Induced Cellular Insulin Resistance via Correction of Plasma Membrane Cholesterol Imbalance Mol. Endocrinol., April 1, 2008; 22(4): 937 - 950. [Abstract] [Full Text] [PDF]

				D. P.Y. Koonen, R. L. Jacobs, M. Febbraio, M. E. Young, C.-L. M. Soltys, H. Ong, D. E. Vance, and J. R.B. Dyck Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity Diabetes, December 1, 2007; 56(12): 2863 - 2871. [Abstract] [Full Text] [PDF]

				J. J. F. P. Luiken, I. Momken, D. D. J. Habets, M. El Hasnaoui, W. A. Coumans, D. P. Y Koonen, J. F. C. Glatz, and A. Bonen Arsenite Modulates Cardiac Substrate Preference by Translocation of GLUT4, But Not CD36, Independent of Mitogen-Activated Protein Kinase Signaling Endocrinology, November 1, 2006; 147(11): 5205 - 5216. [Abstract] [Full Text] [PDF]

				L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue, and J.-L. Vanoverschelde AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H239 - H250. [Abstract] [Full Text] [PDF]

				J. Yang and G. D. Holman Long-Term Metformin Treatment Stimulates Cardiomyocyte Glucose Transport through an AMP-Activated Protein Kinase-Dependent Reduction in GLUT4 Endocytosis Endocrinology, June 1, 2006; 147(6): 2728 - 2736. [Abstract] [Full Text] [PDF]

				G. Chen, P. Liu, G. R. Pattar, L. Tackett, P. Bhonagiri, A. B. Strawbridge, and J. S. Elmendorf Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism Mol. Endocrinol., April 1, 2006; 20(4): 857 - 870. [Abstract] [Full Text] [PDF]

				S. Muntoni Metformin and heart failure: innocent until proven guilty. Diabetes Care, March 1, 2006; 29(3): 751 - 752. [Full Text] [PDF]

				B. Brunmair, K. Staniek, F. Gras, N. Scharf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhausl, et al. Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I: A Common Mechanism Contributing to Their Antidiabetic Actions? Diabetes, April 1, 2004; 53(4): 1052 - 1059. [Abstract] [Full Text] [PDF]

				J. J. F. P. Luiken, S. L. M. Coort, J. Willems, W. A. Coumans, A. Bonen, and J. F. C. Glatz Dipyridamole Alters Cardiac Substrate Preference by Inducing Translocation of FAT/CD36, but Not That of GLUT4 Mol. Pharmacol., March 1, 2004; 65(3): 639 - 645. [Abstract] [Full Text] [PDF]

				J. J.F.P. Luiken, S. L.M. Coort, J. Willems, W. A. Coumans, A. Bonen, G. J. van der Vusse, and J. F.C. Glatz Contraction-Induced Fatty Acid Translocase/CD36 Translocation in Rat Cardiac Myocytes Is Mediated Through AMP-Activated Protein Kinase Signaling Diabetes, July 1, 2003; 52(7): 1627 - 1634. [Abstract] [Full Text] [PDF]

				J. E. Gunton, P. J. D. Delhanty, S.-I. Takahashi, and R. C. Baxter Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2 J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1323 - 1332. [Abstract] [Full Text] [PDF]

				G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF]

				J. J.F.P. Luiken, D. P.Y. Koonen, J. Willems, A. Zorzano, C. Becker, Y. Fischer, N. N. Tandon, G. J. van der Vusse, A. Bonen, and J. F.C. Glatz Insulin Stimulates Long-Chain Fatty Acid Utilization by Rat Cardiac Myocytes Through Cellular Redistribution of FAT/CD36 Diabetes, October 1, 2002; 51(10): 3113 - 3119. [Abstract] [Full Text] [PDF]

				C. Becker, L. Sevilla, E. Tomas, M. Palacin, A. Zorzano, and Y. Fischer The Endosomal Compartment Is an Insulin-Sensitive Recruitment Site for GLUT4 and GLUT1 Glucose Transporters in Cardiac Myocytes Endocrinology, December 1, 2001; 142(12): 5267 - 5276. [Abstract] [Full Text] [PDF]

				Z. Zhang and J. Radziuk Inverse relationship between peripheral insulin removal and action: studies with metformin Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1240 - E1248. [Abstract] [Full Text] [PDF]

				Y. Shimoni, D. Severson, and H. S. Ewart Insulin resistance and the modulation of rat cardiac K+ currents Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H639 - H649. [Abstract] [Full Text] [PDF]

				P. R. Shepherd and B. B. Kahn Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257. [Full Text] [PDF]

				Y. Fischer, C. Becker, and C. Loken Purinergic Inhibition of Glucose Transport in Cardiomyocytes J. Biol. Chem., January 8, 1999; 274(2): 755 - 761. [Abstract] [Full Text] [PDF]

				G.N. Jyothirmayi, B.J. Soni, M. Masurekar, M. Lyons, and T.J. Regan Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 319 - 326. [Abstract] [PDF]

				L. Sevilla, E. Tomas, P. Munoz, A. Guma, Y. Fischer, J. Thomas, B. Ruiz-Montasell, X. Testar, M. Palacin, J. Blasi, et al. Characterization of Two Distinct Intracellular GLUT4 Membrane Populations in Muscle Fiber. Differential Protein Composition and Sensitivity to Insulin Endocrinology, July 1, 1997; 138(7): 3006 - 3015. [Abstract] [Full Text] [PDF]

				Y. Fischer, J. Thomas, L. Sevilla, P. Munoz, C. Becker, G. Holman, I. J. Kozka, M. Palacin, X. Testar, H. Kammermeier, et al. Insulin-induced Recruitment of Glucose Transporter 4(GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes. EVIDENCE OF THE EXISTENCE OF DIFFERENT INTRACELLULAR GLUT4 VESICLE POPULATIONS J. Biol. Chem., March 14, 1997; 272(11): 7085 - 7092. [Abstract] [Full Text] [PDF]